固定的剂量组合的托尔塞米德和矿物质皮质皮质类受体对抗剂
Sunip Banerjee1, Girish B Navasundi2, Agam Vora3
1Senior Interventional Cardiologist, Department of Cardiology, Kolkata Heart Lung Centre, Kolkata, West Bengal, India, Corresponding Author.
The Journal of the Association of Physicians of India
|September 18, 2024
概括
结合torsemide和spironolactone可能有助于管理水和高血压. 由于这种利尿剂组合的潜在副作用和有限的研究,仔细选择患者和剂量至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
背景情况:
- 和高血压是常见的疾病,往往需要尿液治疗.
- 托塞米德是一种循环利尿剂,而螺旋是节利尿剂和矿物质皮质类受体对手 (MRA).
- 这些利尿剂的联合使用可能在控制水分保留和心血管疾病方面提供协同效益.
研究的目的:
- 审查托塞米德和螺旋乳联合使用的临床证据.
- 评估这种组合在治疗,高血压和心力衰竭 (HF) 的有效性.
- 突出患者选择,监测和优化剂量的重要性.
主要方法:
- 临床研究和证据的文献综述.
- 对托塞米德和螺旋乳的药理作用的分析.
- 检查患有水分保留和心力衰竭的患者的结局.
主要成果:
- 这种组合在治疗和高血压方面表现有前途.
- 螺旋龙补充托塞米德通过防止的损失,并提供心血管的好处.
- 有限的研究需要仔细考虑患者特定的因素.
结论:
- 联合托塞米德和螺旋乳治疗是针对特定患者群体的潜在策略.
- 由于潜在的副作用,仔细选择和监测患者至关重要.
- 优化剂量方案对于确保安全性和有效性至关重要.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
396
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
396
Heart Failure Drugs: Diuretics
349
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
349
Antihypertensive Drugs: Potassium-Sparing Diuretics
473
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
473
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Antihypertensive Drugs: Thiazide-Class Diuretics
558
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
558
Antihypertensive Drugs: Angiotensin II Receptor Blockers
600
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
600


